Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia

American Journal of Clinical Pathology

Volumn 112, Issue 6, 1999, Pages 819-827

  Edwards, Robin H ^a,b   Wasik, Mariusz A ^a   Finan, Janet ^a   Rodriguez, Roberto ^a,c   Moore, Jonni ^a   Kamoun, Malek ^a   Rennert, Hanna ^a   Bird, Jennifer ^a,d   Nowell, Peter C ^a   Salhany, Kevin E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Acute promyelocytic leukemia; FACS; FISH; Fluorescence in situ hybridization; Fluorescence activated cell sorting; Immunophenotype; t(15; 17) Translocation

Indexed keywords

CD33 ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; PRIORITY JOURNAL;

EID: 0033492323     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.6.819     Document Type: Article

References (36)

1. de Thé H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature. 1990;347:558-561.
2. Kakizuka A, Miller W, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell. 1991;66:663-674.
3. Pandolfi P, Grignani F, Alcalay M, et al. Structure and origin of the acute promyelocytic leukemia myl/RARA cDNA and characterization of its retinoid-binding and transactivation properties. Oncogen. 1991;7:1285-1292.
4. Chomienne C, Ballerini P, Balitrand N, et al. All-mms retinoic acid in acute promyelocytic leukemias, II: in vitro studies: structure-function relationship. Blood. 1990;76:1710-1717.
5. Degos L, Dombret H, Chomienne C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 1995;85:2643-2653.
6. Soignet S, Fleischauer A, Polyak T, et al. All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study. Cancer Chemother Pharmacol. 1997;40(suppl):S25-S29.
7. 3) in the treatment of acute promyelocytic leukemia (APL), II: clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997;89:3354-3360.
8. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. Br J Haematol. 1976;33:451-458.
9. Bennett JM, Catovsky D, Daniel MT, et al. A variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol. 1980;44:169-170.
10. Davey FR, Davis RB, MacCallum JM, et al. Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol. 1989;30:221-227.
11. Grimwade D, Gorman P, Duprez E, et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood. 1997;90:4876-4885.
12. Zhao L, Chang KS, Estey E, et al. Detection of residual leukemic cells in patients with acute promyelocytic leukemia by the fluorescence in situ hybridization method: potential for predicting relapse. Blood. 1995;85:495-499.
13. Miller WH, Kakizuka A, Frankel SR, et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1992;8:2694-2698.
14. Diverio D, Riccioni R, Mandelli F, et al. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Haematologica. 1995;80:155-160.
15. Diverio D, Riccioni R, Pistilli A, et al. Improved rapid detection of the PML/RARα fusion gene in acute promyelocytic leukemia. Leukemia. 1996;10:1214-1216.
16. Paietta E, Andersen J, Gallagher R, et al. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia. 1994;8:1108-1112.
17. Venditti A, Del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-MO): comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.
18. Geller RB, Zahurak M, Hurwity CA, et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol. 1990;76:340-347.
19. DeRossi G, Avvisati G, Coluzzi S, et al. Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases. Eur J Haemotol. 1990;45:168-171.
20. LoCoco F, Avvisati G, Diverio D, et al. Rearrangements of the RAR-α gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype. Br J Haematol. 1991;78:494-499.
21. O'Connor SJM, Forsyth PD, Dalal S, et al. The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody. Br J Haematol. 1997;99:597-604.
22. Neame PB, Soamboonsrup P, Leber B, et al. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Am J Hematol. 1997;56:131-142.
23. White DL, Hutchins CJ, Haylock DN, et al. Direct analysis of FACS-sorted hemopoietic cell fractions using FISH. Biotechniques. 1995;18:818, 820-821.
24. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83:10-25.
25. Biondi A, Luciano A, Bassan R, et al. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia. 1995;9:1461-1466.
26. Piedras J, Lopez-Karpovitch X, Cardenas R, et al. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant. Cytometry. 1998;32:286-290.
27. Stasi R, Bruno A, Venditti A, et al. A microgranular variant of acute promyelocytic leukemia with atypical morphocytochemical features and an early myeloid phenotype. Leuk Res. 1997;21:575-580.
28. Turhan AG, Lemoine FM, Debert C, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 1995;85:2154-2161.
29. Al-Omar HM, Khalil S, Sher GD, et al. The short form of the PML-RARA gene fusion in acute promyelocytic leukemia (APL) is associated morphologically with the presence of primitive myeloblasts [abstract]. Blood. 1997;90:207b.
30. Keating A, Wang XH, Laraya P. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood. 1994;83:1744-1749.
31. Early E, Moore MAS, Kakizuka A, et al. Transgenic expression of PML/RARα impairs myelopoiesis. Proc Natl Acad Sci U S A. 1996;93:7900-7904.
32. Heim S, Mitelman F. Cancer Cytogenetics. New York, NY: Alan R. Liss; 1995.
33. +lin-) in acute myeloid leukemia. Blood. 1995;86:1139-1147.
34. + subpopulations. Blood. 1995;86:2906-2912.
35. Haferlach T, Loffler H, Nickenig C, et al. Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques for the detection of the translocation t(15;17)(q22;q12). Br J Haematol. 1998;103:93-99.
36. Takatsuki H, Sadamura S, Umemura T, et al. PML/RARα fusion gene is expressed in both granuloid/macrophage and erythroid colonies in acute promyelocytic leukemia. Br J Haematol. 1993;85:477-482.